Status:
UNKNOWN
Impact and Sequelae of High Ventilatory Drive in Critically Ill COVID-19 Patients
Lead Sponsor:
Corporacion Parc Tauli
Collaborating Sponsors:
Althaia Xarxa Assistencial Universitària de Manresa
Hospital Universitario Central de Asturias
Conditions:
COVID-19
Critical Illness
Eligibility:
All Genders
18+ years
Brief Summary
Critically ill COVID-19 patients with acute respiratory failure, in the intensive care unit (ICU), often feature high respiratory drive, determining large inspiratory efforts resulting in high pressur...
Eligibility Criteria
Inclusion
- Adults patients with hypoxemic respiratory failure.
- Admitted to ICU.
- Mechanical ventilation or high flow nasal cannula
Exclusion
- Neurologic patients with brainsteam affection.
Key Trial Info
Start Date :
November 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 15 2024
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT05363332
Start Date
November 15 2021
End Date
November 15 2024
Last Update
May 5 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Candelaria De Haro
Sabadell, Barcelona, Spain, 08208
2
Fundació Althaia
Manresa, Spain
3
Hospital Universitario Central de Asturias
Oviedo, Spain